FDA reviewers back Anoro Ellipta's efficacy

FDA reviewers said Anoro Ellipta umeclidinium bromide/vilanterol from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) is effective for the long-term, once-daily maintenance treatment of airflow obstruction in...